RPAM
Rhenman & Partners Asset Management’s Tenet Healthcare THC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24M | Buy |
136,429
+9,729
| +8% | +$1.71M | 3.04% | 6 |
|
|
2025
Q1 | $17M | Sell |
126,700
-71,000
| -36% | -$9.55M | 1.96% | 21 |
|
|
2024
Q4 | $25M | Sell |
197,700
-23,700
| -11% | -$2.99M | 2.57% | 10 |
|
|
2024
Q3 | $36.8M | Sell |
221,400
-7,600
| -3% | -$1.26M | 2.99% | 5 |
|
|
2024
Q2 | $30.5M | Sell |
229,000
-151,000
| -40% | -$20.1M | 2.92% | 7 |
|
|
2024
Q1 | $39.9M | Buy |
380,000
+28,370
| +8% | +$2.98M | 3.79% | 3 |
|
|
2023
Q4 | $26.6M | Buy |
351,630
+16,630
| +5% | +$1.26M | 2.65% | 10 |
|
|
2023
Q3 | $22.1M | Buy |
335,000
+45,000
| +16% | +$2.97M | 2.38% | 14 |
|
|
2023
Q2 | $23.6M | Sell |
290,000
-120,000
| -29% | -$9.77M | 2.49% | 12 |
|
|
2023
Q1 | $23.6M | Sell |
410,000
-60,750
| -13% | -$3.5M | 2.59% | 12 |
|
|
2022
Q4 | $23M | Buy |
470,750
+126,750
| +37% | +$6.18M | 2.4% | 11 |
|
|
2022
Q3 | $15.3M | Buy |
344,000
+83,000
| +32% | +$3.68M | 1.6% | 26 |
|
|
2022
Q2 | $13.7M | Buy |
261,000
+58,000
| +29% | +$3.05M | 1.56% | 21 |
|
|
2022
Q1 | $17.5M | Sell |
203,000
-7,000
| -3% | -$602K | 1.72% | 21 |
|
|
2021
Q4 | $17.2M | Buy |
210,000
+30,000
| +17% | +$2.46M | 1.14% | 35 |
|
|
2021
Q3 | $12M | Buy |
180,000
+95,000
| +112% | +$6.31M | 0.84% | 47 |
|
|
2021
Q2 | $5.69M | Buy |
+85,000
| New | +$5.69M | 0.39% | 76 |
|